These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 12203142

  • 1. Acute myocardial ischemia after high-dose therapy with BEAM regimen.
    Genet P, Pulik M, Gallet B, Lionnet F, Jondeau K, Touahri T, Laribi K.
    Bone Marrow Transplant; 2002 Aug; 30(4):253-4. PubMed ID: 12203142
    [Abstract] [Full Text] [Related]

  • 2. High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma.
    Wang EH, Chen YA, Corringham S, Bashey A, Holman P, Ball ED, Carrier E.
    Bone Marrow Transplant; 2004 Oct; 34(7):581-7. PubMed ID: 15273714
    [Abstract] [Full Text] [Related]

  • 3. Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma.
    Costa LJ, Micallef IN, Inwards DJ, Johnston PB, Porrata LF, Litzow MR, Ansell SM.
    Br J Haematol; 2008 Oct; 143(2):268-73. PubMed ID: 18699848
    [Abstract] [Full Text] [Related]

  • 4. A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection.
    Phillips GL, Bernstein SH, Liesveld JL, Abboud CN, Becker MW, Constine LS, Ifthikharuddin JJ, Loughner JE, Milner LA, Vesole DH, Friedberg JW.
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1033-42. PubMed ID: 21074630
    [Abstract] [Full Text] [Related]

  • 5. A randomized trial of chemotherapy with carmustine, etoposide, cytarabine, and melphalan (BEAM) plus peripheral stem cell transplantation (PBSCT) vs single-agent high-dose chemotherapy followed by BEAM plus PBSCT in patients with relapsed Hodgkin's disease (HD-R2).
    Glossmann JP, Josting A, Pfistner B, Paulus U, Engert A, German Hodgkin's Lymphoma Study Group (GHSG).
    Ann Hematol; 2002 Aug; 81(8):424-9. PubMed ID: 12223998
    [No Abstract] [Full Text] [Related]

  • 6. [Interdigitating dendritic cell sarcoma of lower extremities resistant to high dose chemotherapy BEAM with peripheral blood stem cell transplantation].
    Adam Z, Veselý K, Krejcí M, Pour L, Fakan F, Soumarová R, Neubauer J, Vanícek J, Cerný J, Kren L, Bolcák K, Smardová L, Hájek R, Mayer J.
    Vnitr Lek; 2009 Feb; 55(2):147-57. PubMed ID: 19348397
    [Abstract] [Full Text] [Related]

  • 7. Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma.
    Bishton MJ, Haynes AP.
    Br J Haematol; 2007 Jan; 136(1):111-3. PubMed ID: 17116129
    [Abstract] [Full Text] [Related]

  • 8. High-dose therapy and autologous stem cell transplantation for Hodgkin's lymphoma in relapse or failure after initial chemotherapy : results of the Centre National de Greffe de Moelle Osseuse de Tunis.
    Torjman L, Ladeb S, Lakhal A, Ben Othman T, Abdelkefi A, Ben Abdeladhim A.
    Tunis Med; 2007 Jan; 85(1):35-8. PubMed ID: 17424707
    [Abstract] [Full Text] [Related]

  • 9. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
    Schütt P, Passon J, Ebeling P, Welt A, Müller S, Metz K, Moritz T, Seeber S, Nowrousian MR.
    Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
    [Abstract] [Full Text] [Related]

  • 10. [Effectiveness of dose-intensive polychemotherapy with autologous hemopoietic cell transplantation for high-grade non-Hodgkin lymphoma].
    Alekseeva IuA, Zaritskiĭ AIu, Medvedeva NV, Mikhaĭlova NB, Zubarovskaia LS, Afanas'ev BV.
    Vopr Onkol; 2003 Feb; 49(1):66-70. PubMed ID: 12715373
    [Abstract] [Full Text] [Related]

  • 11. Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.
    Abrey LE, Moskowitz CH, Mason WP, Crump M, Stewart D, Forsyth P, Paleologos N, Correa DD, Anderson ND, Caron D, Zelenetz A, Nimer SD, DeAngelis LM.
    J Clin Oncol; 2003 Nov 15; 21(22):4151-6. PubMed ID: 14615443
    [Abstract] [Full Text] [Related]

  • 12. Ifosfamide, epirubicin, etoposide (IEV) and autologous peripheral blood progenitor cell transplant: a feasible and effective salvage treatment for lymphoid malignancies.
    Clavio M, Garrone A, Pierri I, Michelis GL, Balocco M, Albarello A, Varaldo R, Canepa P, Miglino M, Ballerini F, Canepa L, Gobbi M.
    Oncol Rep; 2005 Oct 15; 14(4):933-40. PubMed ID: 16142354
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of diverse high-dose regimens followed by autologous peripheral blood stem cell transplantation in consecutive multiple myeloma patients: a single-centre analysis over a 12-year period.
    Haas PS, Bauchmüller K, Kühnemund A, Finke J, Ihorst G, Engelhardt M.
    Ann Hematol; 2006 Mar 15; 85(3):191-3. PubMed ID: 16365747
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of patients with malignant lymphoma with Mini-BEAM reduces the yield of CD34+ peripheral blood stem cells.
    Weaver CH, Zhen B, Buckner CD.
    Bone Marrow Transplant; 1998 Jun 15; 21(11):1169-70. PubMed ID: 9645585
    [No Abstract] [Full Text] [Related]

  • 15. [Effectiveness of high-dose polychemotherapy and autologous hemopoietic cell transplantation in patients with low-grade non-Hodgkin lymphoma].
    Alekseeva IuA, Zaritskiĭ AIu, Medvedeva NV, Mikhaĭlova NB, Zubarovskaia LS, Afanas'ev BV.
    Vopr Onkol; 2002 Jun 15; 48(6):668-72. PubMed ID: 12530261
    [Abstract] [Full Text] [Related]

  • 16. BEAM allogeneic transplantation for patients with Hodgkin's disease who relapse after autologous transplantation is safe and effective.
    Cooney JP, Stiff PJ, Toor AA, Parthasarathy M.
    Biol Blood Marrow Transplant; 2003 Mar 15; 9(3):177-82. PubMed ID: 12652468
    [Abstract] [Full Text] [Related]

  • 17. High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group.
    Colombat P, Lemevel A, Bertrand P, Delwail V, Rachieru P, Brion A, Berthou C, Bay JO, Delepine R, Desablens B, Camilleri-Broët S, Linassier C, Lamy T.
    Bone Marrow Transplant; 2006 Sep 15; 38(6):417-20. PubMed ID: 16951691
    [Abstract] [Full Text] [Related]

  • 18. Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma.
    Leger C, Sabloff M, McDiarmid S, Bence-Bruckler I, Atkins H, Bredeson C, Zhang H, Huebsch L.
    Ann Hematol; 2006 Oct 15; 85(10):723-9. PubMed ID: 16832675
    [Abstract] [Full Text] [Related]

  • 19. Results of autologous transplantation in lymphoma are not improved by increasing the dose of etoposide in the BEAM regimen: a single-centre sequential-cohort study.
    Martín A, Caballero MD, Pérez-Simón JA, López-Holgado N, Mateos MV, Cañizo MC, Miguel JF.
    Bone Marrow Transplant; 2004 Oct 15; 34(8):675-82. PubMed ID: 15334049
    [Abstract] [Full Text] [Related]

  • 20. Treatment of lymphoma relapses after allogeneic hematopoietic stem cell transplantation with intensive chemotherapy followed by infusion of hematopoietic stem cell from the original donor.
    Au WY, Lie AK, Siu LL, Chan EC, Ooi GC, Leung AY, Liang R, Kwong YL.
    Ann Hematol; 2003 Sep 15; 82(9):548-51. PubMed ID: 14504811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.